Product Information
CYCLOBENZAPRINE 7.5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.2402 per EA under NDC 72888001301. Its NADAC has been published 221 times since Jun 1, 2022.
FDA first approved this application on May 31, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888001301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208170FDA Approved
5/31/2017
TE Code
AB
On Market Since
5/31/2017
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has been published 221 times since Jun 1, 2022, and over the history we have for it it has declined 80.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2402 per EA |
|---|---|
| All-time high | $1.2190 (Jul 13, 2022) |
| All-time low | $0.2402 (Aug 19, 2026) |
| 52-week high | $0.3496 |
| 52-week low | $0.2402 |
| Median price | $0.3522 |
| Average price | $0.4336 |
| Largest weekly change | -68.4% (Oct 19, 2022) |
| Weeks tracked | 221 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 7.5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.2402 per EA (NDC 72888001301), effective Aug 19, 2026.
How has the price of CYCLOBENZAPRINE 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has declined 80.3%. It has been tracked across 221 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 7.5 MG TABLET?
Since Jun 1, 2022, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has ranged from a low of $0.2402 (Aug 19, 2026) to a high of $1.2190 (Jul 13, 2022), with a median of $0.3522 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 7.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CYCLOBENZAPRINE 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 7.5 MG TABLET?
CYCLOBENZAPRINE 7.5 MG TABLET (NDC 72888001301) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.